Status:
COMPLETED
Long Term Follow-up of Pegylated-Interferon Alpha-2b
Lead Sponsor:
Foundation for Liver Research
Conditions:
Chronic Hepatitis B
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study was to investigate the long term outcome of Peginterferon alpha-2b with or without the addition of lamivudine in patients with chronic hepatitis B
Detailed Description
Interferon alpha therapy is a generally accepted agent for the treatment of chronic HBV infection and effective in about one third of patients. Recently, in the HBV 99-01 study, pegylated interferon a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with chronic Hepatitis B who participated in the HBV 99-01 study
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT00146705
Start Date
May 1 2005
End Date
September 1 2006
Last Update
August 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Rotterdam
Rotterdam, Dr Molewaterplein 40, Netherlands, 3015 GD